The innovative AI tool predicts pediatric cancer recurrence with unprecedented accuracy, significantly improving outcomes in children battling brain tumors.A recent study from Mass General Brigham reveals that this advanced cancer prediction tool, which analyzes MRI scans over time, outperforms traditional methods in assessing the risk of relapse in pediatric patients.